Stock listing

Percheron Therapeutics Limited

Selected listing: A3E1W6 · LSX · EUR · DE

Percheron Therapeutics Limited (LS Exchange: A3E1W6), Health Technology. Latest release Aug 31, 2026: Percheron raises $2.3m to fully fund clinical trial in AML

A3E1W6:LSXEURDEUpdated October 2, 2026

Ticker: LS Exchange: A3E1W6
Asset type: Stock
Sector: Health Technology
Industry: Pharmaceuticals: Major
Exchange: LS Exchange
Currency: EUR

Latest news from Percheron Therapeutics Limited

Percheron raises $2.3m to fully fund clinical trial in AML

August 31, 2026

Vanderbilt Health to conduct clinical trial of HMBD-002

August 27, 2026

Percheron Therapeutics Announces CEO Succession

August 9, 2026

Results of Entitlement Offer

April 14, 2026

Prospectus - Non-renounceable Entitlement Offer

March 15, 2026

All Percheron Therapeutics Limited news →

Research Percheron Therapeutics Limited

Percheron Therapeutics Limited company profile

View the public company page for Percheron Therapeutics Limited on 6ix.

Percheron Therapeutics Limited news

Read company news and market updates connected to Percheron Therapeutics Limited.

Percheron Therapeutics Limited investor events

Find investor webinars, events, and replay context for Percheron Therapeutics Limited.